CORTEF 20 MG
HYDROCORTISONE : 20 MG · DIN 00030929 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is CORTEF?
CORTEF 20 MG contains HYDROCORTISONE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 00030929, held by PFIZER CANADA ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 27-May-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CORTEF used for?
Endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, and gastrointestinal diseases; tuberculous meningitis; trichinosis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00030929 |
|---|---|
| Brand name | CORTEF |
| Generic / active ingredient | HYDROCORTISONE : 20 MG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 20 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | H02AB09 HYDROCORTISONE |
| AHFS class | 68:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-May-2005 |
| Original market date | 1954-12-31 00:00:00 |
How is it administered?
Initial dosage: 20 to 240 mg/day. Individualize based on disease severity and response. Reduce gradually for maintenance or discontinuation. Take missed doses as soon as possible.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly specified in provided text (refer to section 11 of full monograph).
How is it supplied?
10 mg and 20 mg tablets (specific bottle counts not provided in text, but described as scored/compressed tablets).
Contraindications
Systemic fungal infections; hypersensitivity to hydrocortisone; live or live-attenuated vaccines (immunosuppressive doses); herpes simplex of the eye; vaccinia and varicella.
Warnings and precautions
HPA axis suppression; risk of GI perforation; cardiovascular effects (hypertension, edema); susceptibility to infections; pheochromocytoma crisis; may aggravate Cushing’s syndrome or diabetes.
What can be used instead?
Other Canadian products sharing ATC code H02AB09 HYDROCORTISONE. 8 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-HYDROCORTISONE | 10 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02524465 |
| AURO-HYDROCORTISONE | 20 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02524473 |
| CORTEF | 10 MG | Tablet | PFIZER CANADA ULC | MARKETED | DIN 00030910 |
| SOLU-CORTEF | 1 G | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00030635 |
| SOLU-CORTEF | 100 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00030600 |
| SOLU-CORTEF | 250 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00030619 |
| SOLU-CORTEF | 500 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00030627 |
| A-HYDROCORT INJ 1000MG/8ML | 1 G | POWDER FOR SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00888222 |
| A-HYDROCORT INJ 100MG/2ML | 100 MG | POWDER FOR SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00888230 |
| A-HYDROCORT INJ 250MG/2ML | 250 MG | POWDER FOR SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00888206 |
Who else supplies HYDROCORTISONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. HYDROCORTISONE appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.